The bill would establish a program to address sickle cell disease and other heritable hemoglobinopathies. No publicly available information describes the program’s activities or services.
No publicly available information explains who could take part or how the program might affect patients and families.
No publicly available information describes expenses.
No publicly available information describes proponents’ views.
No publicly available information describes opponents’ views.